Is DexCom a go-to health care stock? [Video]

Giles Coghlan LLB, Lth, MA Financial Source

DexCom, Inc. is a global company headquartered in San Diego, California, that focuses on the development, manufacturing, and distribution of continuous glucose monitoring (CGM) systems for managing diabetes. These systems enable individuals with diabetes to monitor their blood glucose levels consistently throughout the day, aiding in effective diabetes management and treatment decision-making. With a strong international presence, DexCom serves customers worldwide, contributing significantly to advancements in diabetes care through its innovative CGM technology.

When there are recessionary risks healthcare companies can remain profitable as consumers understandably prioritize health care. DexCom has some impressive seasonal patterns outlined which have been found using the Seasonax screener feature.

Over the last 15 years, DexCom has gained 14 out of 15 times. With a very strong seasonal pattern and excellent annualized returns of over 115% and an average of 13.18%, the main question is if it is worth looking at DexCom as we head into the summer months.

Major Trade Risks: The major trade risk here is for stock-specific news to DexCom or if the seasonal pattern fails to hold up this year.

Learn more about HYCM

Author

Giles Coghlan LLB, Lth, MA

Financial Source

Giles is the chief market analyst for Financial Source. His goal is to help you find simple, high-conviction fundamental trade opportunities. He has regular media presentations being featured in National and International Press.

EUR/USD softens below 1.1800 on Fed hawkish remarks

The EUR/USD pair edges lower to around 1.1775 during the early Asian session on Wednesday, pressured by a renewed US Dollar demand. Traders await the US President Donald Trump's State of the Union address later on Wednesday for clarity on fiscal policies.

GBP/USD regains 1.3500 and above

GBP/USD extends its advance for the third day in a row on Tuesday, this time retesting the area beyond the 1.3500 hurdle. Cable’s uptick comes despite decent gains in the Greenback and the dovish message from the BoE’s Bailey at the UK Parliament.

Gold bounces back above $5,150 ahead Trump's State of the Union speech

Gold finds fresh demand and regains the $5,150 level following the previous day's pullback from the monthly peak as traders await Trump's State of the Union address. In the meantime, trade-related uncertainties and geopolitical risks seem to act as a tailwind for the safe-haven bullion.

Hyperliquid registers mild gains following CoinShares' ETP launch

Hyperliquid registered a 3% gain on Tuesday after CoinShares announced the launch of its Physical Hyperliquid Staking exchange-traded product, offering investors exposure to the token's price and staking yields.

The Citrini report: How a debatable AI narrative can shake Wall Street

That AI-related headline alone was enough to rattle investors.US stocks slid sharply on Monday after a widely circulated Citrini Research memo outlined a hypothetical “2028 Global Intelligence Crisis”, warning that rapid AI adoption could push US unemployment into double digits as early as by mid-2028.

XRP pressured by weak ETF flows and declining retail interest

Ripple (XRP) is edging lower, trading above its intraday low of $1.32 at the time of writing on Tuesday. The decline from its weekly opening of $1.39 reflects heightened volatility in the broader cryptocurrency market, accentuated by tariff-triggered uncertainty.